National Heart, Lung, and Blood Institute; Notice of Meeting, 14952-14953 [2019-07250]

Download as PDF 14952 Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices • Office of Population Affairs Æ Office of Adolescent Health—Teen Pregnancy Prevention Program Under Part C, section C–G, Organization, revise to include that the Office of Population Affairs will manage the Office of Adolescent Health (OAH) and the activities managed by OAH. Section C–G will incorporate the current reference to section C–R: The Office of Adolescent Health is headed by a Director who reports to the Assistant Secretary for Health. Under Section C–G. Functions, retitle all references to the Office of Adolescent Health (ACR) under Part C, Section C– R, to the Office of Population Affairs (ACG). Under Section C–R. Delete all other organizational references to the Office of Adolescent Health (AGR). II. Delegations of Authority: All delegations and redelegations of authority made to officials and employees of affected organizational components will continue in them or their successors pending further redelegation, if allowed, provided they are consistent with this reorganization. (Authority: 44 U.S.C. 3101) Alex M. Azar II, Secretary. [FR Doc. 2019–07124 Filed 4–10–19; 4:15 pm] BILLING CODE 4150–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Statement of Organization, Functions, and Delegations of Authority Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, HHS. ACTION: Notice. AGENCY: The Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion organization has modified its organizational structure. DATES: This new organizational structure was approved by the Secretary of Health and Human Services and takes effect on April 6, 2019. FOR FURTHER INFORMATION CONTACT: Tara Broido, Acting Director, Office of Communications, Office of the Assistant Secretary for Health, 200 Independence Ave. SW, Room 715–G, Washington, DC 20201 Phone 202.690.7694. SUPPLEMENTARY INFORMATION: Part A (Office of the Secretary, U.S. Department of Health and Human Services) of the Statement of Organization, Functions, and Delegations of Authority of the jbell on DSK30RV082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:18 Apr 11, 2019 Jkt 247001 Department of Health and Human Services (60 FR 27804, dated October 31, 1995, and corrected at 75 FR 53304, August 31, 2010, and amended most recently at 82 FR 3005, dated January 5, 2017) is amended to reflect the reorganization of the Office of Disease Prevention and Health Promotion (ODPHP) to merge the President’s Council on Sports, Fitness and Nutrition (PCSFN), Office of the Assistant Secretary for Health (OASH) activities to be managed under the Office of Disease Prevention and Health Promotion. This reorganization is being undertaken to create a more effective structure that better reflects the two offices’ missions and streamlines the office’s operations. Under Part C, Section C–L, add the current reference: The Office of Disease Prevention and Health Promotion (ODPHP) is headed by the Director, will comprise of the following: The Office of Disease Prevention and Health Promotion and the Office of the President’s Council on Sports, Fitness, and Nutrition (PCSFN). The ODPHP will be responsible for managing the activities of ODPHP and will manage the PCSFN, to be headed by the Executive Director of the PCSFN. The Executive Director of PCSFN will be a Senior Advisor to ODPHP and report to the Deputy Assistant Secretary for Health for Operations. • Office of Disease Prevention and Health Promotion Æ Office of the President’s Council on Sports, Fitness, and Nutrition Under Part C, Section C–E, Organization and Function, make the following changes: • Retitle all references to the function of the Office of the President’s Council on Sports, Fitness, and Nutrition (ACE) to the Office of the President’s Council on Sports, Fitness, and Nutrition (ACL). • Delete all references to the organizational structure of the Office of the President’s Council on Sports, Fitness, and Nutrition (ACE) and replace with: The Office of the President’s Council on Sports, Fitness, and Nutrition (ACL) is headed by the Executive Director of the PCSFN. The Executive Director of PCSFN will be a Senior Advisor to ODPHP and report to the Deputy Assistant Secretary for Health for Operations. II. Delegations of Authority: All delegations and re-delegations of authority made to officials and employees of affected organizational components will continue in them or their successors pending further redelegation, if allowed, provided they are consistent with this reorganization. PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 (Authority: 44 U.S.C. 3101) Alex M. Azar II, Secretary. [FR Doc. 2019–07125 Filed 4–10–19; 4:15 pm] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Complications of Hemolysis and Transfusion Therapy. Date: May 7, 2019. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Melissa E. Nagelin, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7202, Bethesda, MD 20892, 301–827–7951, nagelinmh2@ nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; MESA Field Centers. Date: May 20, 2019, Time: 8:00 a.m. to 9:00 a.m. Agenda: To review and evaluate contract proposals, Place: Crowne Plaza Washington National Airport, 1489 Jefferson Davis Hwy., Arlington, VA 22202. Contact Person: William J. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892–7924, 301–827–7938, johnsonw@ nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; MESA Coordinating Center. Date: May 20, 2019. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. E:\FR\FM\12APN1.SGM 12APN1 jbell on DSK30RV082PROD with NOTICES Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices Place: Crowne Plaza Washington National Airport, 1480 Crystal Drive, Arlington, VA 22202. Contact Person: William J. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892–7924, 301–827–7938, johnsonw@ nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Mechanisms of Blood Pressure Regulation Program Project Grant Review. Date: May 23, 2019. Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Shelley S. Sehnert, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7206, Bethesda, MD 20892–7924, 301–435–0303, ssehnert@ nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Short-Term Experience in Research. Date: May 29, 2019. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892, 301–827–7969, Pintuccig@ nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Institutional Training Grants. Date: May 30, 2019. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review Officer, Office of Scientific Review, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892, 301–827–7969, Pintuccig@ nhlbi.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) VerDate Sep<11>2014 18:18 Apr 11, 2019 Jkt 247001 Dated: April 8, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. 14953 the environment while replacing, reducing, or refining animal use. ICCVAM’s goals include promotion of national and international partnerships between governmental and [FR Doc. 2019–07250 Filed 4–11–19; 8:45 am] nongovernmental groups, including BILLING CODE 4140–01–P academia, industry, advocacy groups, and other key stakeholders. To foster DEPARTMENT OF HEALTH AND these partnerships ICCVAM initiated HUMAN SERVICES annual public forums in 2014 to share information and facilitate direct National Institutes of Health communication of ideas and suggestions from stakeholders (79 FR 25136). Interagency Coordinating Committee This year’s meeting will be held on on the Validation of Alternative May 23, 2019, at the National Institutes Methods; Notice of Public Meeting; of Health (NIH) in Bethesda, MD. The Request for Public Input meeting will include presentations by NICEATM and ICCVAM members on AGENCY: National Institutes of Health, current activities related to the HHS. development and validation of ACTION: Notice. alternative test methods and SUMMARY: The Interagency Coordinating approaches, including activities relevant Committee on the Validation of to implementation of the strategic Alternative Methods (ICCVAM) will roadmap for establishing new hold a public forum to share approaches to evaluate the safety of information and facilitate direct chemicals and medical products in the communication of ideas and suggestions United States (83 FR 7487). from stakeholders. Interested persons Following each presentation, there may attend in person or view the will be an opportunity for participants meeting remotely by webcast. Time will to ask questions of the ICCVAM be set aside for questions and public members. Instructions for submitting statements on the topics discussed. questions will be provided to remote Registration is requested for both public participants prior to the webcast. The attendance and oral statements, and agenda will also include time for required for remote access. Information participants to make public oral about the meeting and registration are statements relevant to the ICCVAM available at https://ntp.niehs.nih.gov/go/ mission and current activities. iccvamforum-2019. Preliminary Agenda and Other DATES: Meeting: May 23, 2019, 9:00 a.m. Meeting Information: The preliminary to approximately 4:00 p.m. Eastern agenda, list of discussion topics, Daylight Time (EDT). background materials, ICCVAM roster, Registration for Onsite Meeting: and public statements submitted prior Deadline is May 10, 2019. to the meeting will be posted by May 17 Registration for Webcast: Deadline is at https://ntp.niehs.nih.gov/go/ May 23, 2019. iccvamforum-2019. Interested Submission of Oral Public Statements: individuals are encouraged to visit this Deadline is May 10, 2019. web page to stay abreast of the most ADDRESSES: Meeting Location: William current meeting information. H. Natcher Conference Center, National Meeting and Registration: This Institutes of Health, Bethesda, MD meeting is open to the public with time 20892. scheduled for questions and oral public Meeting web page: The preliminary statements following presentations from agenda, registration, and other meeting ICCVAM and NICEATM. The public materials are at https://ntp.niehs.nih.gov/ may attend the meeting at NIH, where go/iccvamforum-2019. attendance is limited only by the space FOR FURTHER INFORMATION CONTACT: Dr. available, or view remotely by webcast. Warren Casey, Director, National Those planning to attend the meeting in Toxicology Program Interagency Center person are encouraged to register at for the Evaluation of Alternative https://ntp.niehs.nih.gov/go/ Toxicological Methods (NICEATM); iccvamforum-2019 by May 10, 2019, to email: warren.casey@nih.gov; telephone: facilitate planning for appropriate (984) 287–3118. meeting space. Those planning to view the webcast must register at https:// SUPPLEMENTARY INFORMATION: ntp.niehs.nih.gov/go/iccvamforumBackground: ICCVAM, a 2019; registration will be available congressionally mandated committee, through May 23, 2019. The URL for the promotes the development and webcast will be provided in the email validation of alternative testing strategies that protect human health and confirming registration. PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Pages 14952-14953]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07250]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Complications of Hemolysis and Transfusion 
Therapy.
    Date: May 7, 2019.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Melissa E. Nagelin, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7202, Bethesda, MD 20892, 301-827-7951, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; MESA Field Centers.
    Date: May 20, 2019,
    Time: 8:00 a.m. to 9:00 a.m.
    Agenda: To review and evaluate contract proposals,
    Place: Crowne Plaza Washington National Airport, 1489 Jefferson 
Davis Hwy., Arlington, VA 22202.
    Contact Person: William J. Johnson, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7178, Bethesda, MD 20892-7924, 301-827-7938, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; MESA Coordinating Center.
    Date: May 20, 2019.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.

[[Page 14953]]

    Place: Crowne Plaza Washington National Airport, 1480 Crystal 
Drive, Arlington, VA 22202.
    Contact Person: William J. Johnson, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7178, Bethesda, MD 20892-7924, 301-827-7938, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Mechanisms of Blood Pressure Regulation 
Program Project Grant Review.
    Date: May 23, 2019.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Shelley S. Sehnert, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7206, Bethesda, MD 20892-7924, 301-435-0303, 
[email protected].
    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; NHLBI Short-Term Experience in Research.
    Date: May 29, 2019.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7192, Bethesda, MD 20892, 301-827-7969, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; NHLBI Institutional Training Grants.
    Date: May 30, 2019.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7192, Bethesda, MD 20892, 301-827-7969, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: April 8, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-07250 Filed 4-11-19; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.